How a Physician Developed a Serum That Outperforms Treatments 4x the Price
Most skincare products are developed by brand teams, not by physicians. A marketing brief defines the product concept, a contract manufacturer formulates it to a cost target, and the finished product is priced based on positioning and perceived luxury, not based on the concentration of active ingredients. Understanding this process explains why so many expensive products don't deliver the results their price point implies.
How Oliē's Peptide Serum Was Actually Built
Dr. Neves started with a clinical question: what concentration of bioactive peptides, specifically GHK-Cu and Matrixyl 3000, produces measurable changes in collagen synthesis in aging skin? The answer came from the published research. Studies on Matrixyl 3000 showing significant wrinkle reduction used concentrations of 3% or higher. GHK-Cu research demonstrating collagen I stimulation used concentrations in the 1% to 5% range.
The formulation target became: a combined peptide complex at 10%, with a lipid-based delivery system to ensure bioavailability, supported by hyaluronic acid and niacinamide at therapeutic concentrations. That's the Oliē Peptide Anti-Aging Serum. The starting point was efficacy data, not a marketing brief.
The Price-Concentration Gap in Luxury Skincare
A $300 department store serum that lists "peptide complex" as its 18th ingredient contains peptides at a fraction of a percent. At that concentration, no meaningful fibroblast activation occurs. The product provides a surface aesthetic experience: it feels luxurious, it smells sophisticated, and it may provide temporary hydration from its primary humectants. But it cannot produce the collagen stimulation that justifies its price from a clinical standpoint.
Oliē's Peptide Anti-Aging Serum is priced at $74.95 for a 30-day supply. The 10% peptide complex that defines it is formulated at a concentration that corresponds to the clinical research. That's the comparison: not brand prestige, but active ingredient concentration relative to the evidence base.
Dr. Neves explains the economics directly: "The cost of formulating at 10% peptide complex is higher per unit than formulating at 0.5%. But when you're designing a product based on what actually works rather than what looks impressive on a label, you accept that cost. The alternative is a product that can't do what it claims."
The Independent Verification Question
One of the most important questions women can ask about any skincare product is: what is the concentration of the active ingredient, and does that concentration match what the clinical research actually used? For most luxury products, this comparison is unfavorable. The gap between the clinical evidence and what's in the jar is significant.
For Oliē, the answer is in the formulation: 10% peptide complex, Korean cosmeceutical standard delivery system, physician-designed concentration targets drawn from the published literature.
The 90-Day Test
The most direct verification is the result at 90 days. Clinical peptide research consistently shows measurable structural skin improvements at this timeframe when the ingredients are present at therapeutic concentrations. The women who have gone through 90 days of consistent Oliē use report results that track with what the clinical literature predicts, and at a price point that doesn't require them to choose between skincare and their budget.
See the Full Protocol and understand exactly what 90 days of physician-formulated peptide support delivers.
